Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1081067.RAI5Fh1oRse2o-Mvl0Al_6Iw_wBGvze76DPbkeRu5_Olo130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1081067.RAI5Fh1oRse2o-Mvl0Al_6Iw_wBGvze76DPbkeRu5_Olo130_assertion type Assertion NP1081067.RAI5Fh1oRse2o-Mvl0Al_6Iw_wBGvze76DPbkeRu5_Olo130_head.
- NP1081067.RAI5Fh1oRse2o-Mvl0Al_6Iw_wBGvze76DPbkeRu5_Olo130_assertion description "[Tubes contained either growth factor-reduced basement membrane extract (BME)-alone (negative control) or BME-containing vascular endothelial growth factor (VEGF)-D (positive control for lymphangiogenesis) or FGF-2/VEGF-A (positive control for angiogenesis) or a high VEGF-D-expressing breast cancer cell line MDA-MD-468LN (468-LN), or VEGF-D-silenced 468LN.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1081067.RAI5Fh1oRse2o-Mvl0Al_6Iw_wBGvze76DPbkeRu5_Olo130_provenance.
- NP1081067.RAI5Fh1oRse2o-Mvl0Al_6Iw_wBGvze76DPbkeRu5_Olo130_assertion evidence source_evidence_literature NP1081067.RAI5Fh1oRse2o-Mvl0Al_6Iw_wBGvze76DPbkeRu5_Olo130_provenance.
- NP1081067.RAI5Fh1oRse2o-Mvl0Al_6Iw_wBGvze76DPbkeRu5_Olo130_assertion SIO_000772 23711825 NP1081067.RAI5Fh1oRse2o-Mvl0Al_6Iw_wBGvze76DPbkeRu5_Olo130_provenance.
- NP1081067.RAI5Fh1oRse2o-Mvl0Al_6Iw_wBGvze76DPbkeRu5_Olo130_assertion wasDerivedFrom befree-2016 NP1081067.RAI5Fh1oRse2o-Mvl0Al_6Iw_wBGvze76DPbkeRu5_Olo130_provenance.
- NP1081067.RAI5Fh1oRse2o-Mvl0Al_6Iw_wBGvze76DPbkeRu5_Olo130_assertion wasGeneratedBy ECO_0000203 NP1081067.RAI5Fh1oRse2o-Mvl0Al_6Iw_wBGvze76DPbkeRu5_Olo130_provenance.